Insulin Detemir No pharmacokinetic interaction was observed between liraglutide injection and insulin detemir when separate subcutaneous injections of insulin detemir 0.5 Unit/kg (single-dose) and liraglutide injection 1.8 mg (steady state) were administered in patients with type 2 diabetes mellitus
This mechanism explains why some people on retatrutide never feel truly hungry but also never feel truly energized
Leptin and obesity: role and clinical implication
A lot of people get scared when they feel hunger on this medication thinking its not working
When to Get Help Seek medical attention for severe or persistent symptoms or any concerning reactions
however, these remain investigational and their clinical significance requires further study For detailed pharmacology and mechanism of action, refer to the MHRA Electronic Medicines Compendium (EMC) Summaries of Product Characteristics (SmPCs) for individual GLP-1 receptor agonists (e.g., semaglutide [Ozempic/Wegovy], liraglutide [Victoza/Saxenda], dulaglutide [Trulicity]) and the corresponding EMA EPARs
